Dive deeper into MedMorphIQ
A next-generation cancer diagnostics platform built to meet the precision and efficiency demands of modern pathology.
An end-to-end workflow for biomarker quantification.
MedMorphIQ offers an end-to-end workflow for biomarker quantification, combining intelligent auto-counting with expert-guided review to ensure clinical-grade reliability. Its outputs, cleanly formatted PDF and PNG reports, are optimized for integration into existing pathology systems, enabling rapid turnaround without disrupting established protocols.
MedMorphIQ quantifies the full breast IHC panel, Ki-67, ER, PR, and HER2, directly from standard microscope fields of view, with no whole-slide scanner required. The platform is built to scale across additional biomarkers and histopathological applications spanning a wide range of cancer types.
Four steps, seconds apart.
Upload
Drop in a raw pathology image, no special formatting required.
Auto-count
AI detects and quantifies staining across Ki-67, ER, PR, and HER2.
Human in the loop
Expert-guided review keeps every result clinical-grade and reliable.
Report
Export publication-ready PDF & PNG reports, workflow-integrated.
Raw pathology images → actionable results.
MedMorphIQ’s AI seamlessly transforms raw pathology images into actionable, expert-level results, see the process side by side.
